Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of EC0225 for the Treatment of Refractory or Metastatic Tumors

This study has been completed.
Information provided by (Responsible Party):
Endocyte Identifier:
First received: February 27, 2007
Last updated: March 8, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)